Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. Its geographical areas include Canada, the United States, Saudi Arabia, Mexico, Costa Rica and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Comment by segltechon Sep 13, 2018 5:02pm
69 Views
Post# 28616007

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Who intends to go to the AGM?

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Who intends to go to the AGM?They seem to have a product or implemtation issue as all of their startups seem to fall off sharply after a short period of time. The only 2 countries they had small revenue increases in the last quarter were US and Canada. However, it would be a big plus if they are able to concentrate on these markets and maintain substantial growth in the next few quarters. I believe they are in too many countries now and it is placiing a strain on their limited human and monetary resources. They need to seriosly review and revise their business plan accordinally as they are getting in serious financial difficulty . I have been invested in this stock for a number of years and like many of you, I am very disappointed with their performance to date. I have lost confidence in Andre's judgement and believe he should step down before the current yearend unless a real turn around occurs.  They seem to be continually diluting the shareholder value with the frequent issuing of more shares due to their inability to generate real revenue. They have to realize that time is not on their side and focus their resources on strategic markets that will generate the required revenue in the near term.
Bullboard Posts